Applied DNA Sciences Supports Jet Propulsion Laboratory in New Counterfeit Prevention Authentication Program

Share Article

NASA's Jet Propulsion Laboratory (JPL), has received training on DNA authentication as part of effort to asses the latest ideas and technologies related to counterfeit risk mitigation.

News Image

Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a biotechnology firm that provides DNA-based anti-counterfeiting technology and product authentication solutions, announced today that NASA's Jet Propulsion Laboratory (JPL), has received training on DNA authentication as part of its effort to assess the latest ideas and technologies related to counterfeit risk mitigation.

JPL also intends to include information about SigNature® DNA marking, including the CPA Program, as part of its influential Counterfeit Awareness Training Program. The latter has the participation of all major NASA facilities and many of its largest suppliers.

APDN's CPA Program empowers end-users to leverage the Defense Logistics Agency (DLA) initiative which requires SigNature DNA marking on certain high-reliability components. Over one half-million parts have been marked, with 30 companies participating, 14 of them original equipment or component manufacturers, prime defense contractors, or authorized distributors.

JPL, managed by the California Institute of Technology, has been a seminal force in space exploration, and its supply chain encompasses many of the most critical aerospace suppliers.

America's first satellite, Explorer 1, which launched in 1958, was created at JPL. The lab later sent the first robotic craft to the moon and out across the solar system, reconnoitering all of the planets.

JPL manages such current missions as the Mars Curiosity rover, Juno to Jupiter, Dawn to Vesta and Ceres, and the Spitzer Space Telescope. Later this year it will launch three new Earth orbiting missions – RapidScat, Orbiting Carbon Observatory 2 and the Soil Moisture Active Passive mission.

Janice Meraglia, Vice President of Government and Military Programs at Applied DNA Sciences, commented: "We appreciate the support and participation of JPL in the SigNature DNA Counterfeit Prevention Authentication program, as part of their mission-assurance effort. This is especially important given the influence and prestige of the laboratory in the industrial and scientific realms."

Said Dr. James A. Hayward, CEO and President of Applied DNA Sciences: "Our SigNature DNA platform for electronics is ready for the most demanding jobs, as exemplified by JPL's missions. We are confident that our platform will be acceptable to and prepared for participants supply-chain-wide."

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for the quarterly period ended December 31, 2013) and Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mitchell Miller

Debbie Bailey
Visit website